Trends in the Parent-report of Health Care Provider-diagnosed and Medicated Attention-deficit/hyperactivity Disorder: United States, 2003-2011

Overview

Journal J Am Acad Child Adolesc Psychiatry

Publisher Elsevier

Specialties Pediatrics
Psychiatry

Date 2013 Dec 18

PMID 24342384

Citations 438

Authors

Susanna N Visser

Melissa L Danielson

Rebecca H Bitsko

Joseph R Holbrook

Michael D Kogan

Reem M Ghandour

Ruth Perou

Stephen J Blumberg

Affiliations

Soon will be listed here.

Abstract

Objective: Data from the 2003 and 2007 National Survey of Children's Health (NSCH) reflect the increasing prevalence of parent-reported attention-deficit/hyperactivity disorder (ADHD) diagnosis and treatment by health care providers. This report updates these prevalence estimates for 2011 and describes temporal trends.

Method: Weighted analyses were conducted with 2011 NSCH data to estimate prevalence of parent-reported ADHD diagnosis, current ADHD, current medication treatment, ADHD severity, and mean age of diagnosis for U.S. children/adolescents aged 4 to 17 years and among demographic subgroups. A history of ADHD diagnosis (2003-2011), as well as current ADHD and medication treatment prevalence (2007-2011), were compared using prevalence ratios and 95% confidence intervals.

Results: In 2011, 11% of children/adolescents aged 4 to 17 years had ever received an ADHD diagnosis (6.4 million children). Among those with a history of ADHD diagnosis, 83% were reported as currently having ADHD (8.8%); 69% of children with current ADHD were taking medication for ADHD (6.1%, 3.5 million children). A parent-reported history of ADHD increased by 42% from 2003 to 2011. Prevalence of a history of ADHD, current ADHD, medicated ADHD, and moderate/severe ADHD increased significantly from 2007 estimates. Prevalence of medicated ADHD increased by 28% from 2007 to 2011.

Conclusions: Approximately 2 million more U.S. children/adolescents aged 4 to 17 years had been diagnosed with ADHD in 2011, compared to 2003. More than two-thirds of those with current ADHD were taking medication for treatment in 2011. This suggests an increasing burden of ADHD on the U.S. health care system. Efforts to further understand ADHD diagnostic and treatment patterns are warranted.

Citing Articles

Linking Electronic Health Record Prescribing Data and Pharmacy Dispensing Records to Identify Patient-Level Factors Associated With Psychotropic Medication Receipt: Retrospective Study.

Wu P, Hurst J, French A, Chrestensen M, Goldstein B JMIR Med Inform. 2025; 13:e63740.

PMID: 40035724 PMC: 11895725. DOI: 10.2196/63740.

Exploring the Intersection of ADHD and Music: A Systematic Review.

Saville P, Kinney C, Heiderscheit A, Himmerich H Behav Sci (Basel). 2025; 15(1).

PMID: 39851869 PMC: 11762814. DOI: 10.3390/bs15010065.

Assessing the Causal Relationship Between Various Immune Cells and Attention Deficit Hyperactivity Disorder: Mendelian Randomization Study.

Ge Q, Li Z, Meng W, Cai C, Qiu M, Liu Y Brain Behav. 2025; 15(1):e70280.

PMID: 39829120 PMC: 11743990. DOI: 10.1002/brb3.70280.

Prevalence of Obstructive Sleep Apnea in Vietnamese Children with Attention Deficit Hyperactivity Disorder (ADHD).

Nguyen-Thi-Phuong M, Nguyen-Thi-Thanh M, Nguyen-Thi-Dieu T, Duong-Quy S Pulm Ther. 2025; 11(1):69-80.

PMID: 39808265 PMC: 11861823. DOI: 10.1007/s41030-024-00286-8.

Impulsivity in ADHD and Borderline Personality Disorder: A Systematic Review of Gray and White Matter Variations.

Franczak L, Podwalski P, Wysocki P, Dawidowski B, Jedrzejewski A, Jablonski M J Clin Med. 2024; 13(22).

PMID: 39598050 PMC: 11594719. DOI: 10.3390/jcm13226906.

References

Dempster R, Wildman B, Keating A . The role of stigma in parental help-seeking for child behavior problems. J Clin Child Adolesc Psychol. 2012; 42(1):56-67. DOI: 10.1080/15374416.2012.700504. View

Loe I, Feldman H . Academic and educational outcomes of children with ADHD. J Pediatr Psychol. 2007; 32(6):643-54. DOI: 10.1093/jpepsy/jsl054. View

Visser S, Danielson M, Bitsko R, Perou R, Blumberg S . Convergent validity of parent-reported attention-deficit/hyperactivity disorder diagnosis: a cross-study comparison. JAMA Pediatr. 2013; 167(7):674-5. PMC: 4486473. DOI: 10.1001/jamapediatrics.2013.2364. View

Olfson M, Crystal S, Huang C, Gerhard T . Trends in antipsychotic drug use by very young, privately insured children. J Am Acad Child Adolesc Psychiatry. 2010; 49(1):13-23. DOI: 10.1097/00004583-201001000-00005. View

Chai G, Governale L, McMahon A, Trinidad J, Staffa J, Murphy D . Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics. 2012; 130(1):23-31. DOI: 10.1542/peds.2011-2879. View

Boyle C, Boulet S, Schieve L, Cohen R, Blumberg S, Yeargin-Allsopp M . Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics. 2011; 127(6):1034-42. DOI: 10.1542/peds.2010-2989. View

Pelham W, Foster E, Robb J . The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambul Pediatr. 2007; 7(1 Suppl):121-31. DOI: 10.1016/j.ambp.2006.08.002. View

Harty S, Ivanov I, Newcorn J, Halperin J . The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol. 2011; 21(4):331-9. PMC: 3157746. DOI: 10.1089/cap.2010.0074. View

Akinbami L, Liu X, Pastor P, Reuben C . Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009. NCHS Data Brief. 2011; (70):1-8. View

10.

Smith P, Hoaglin D, Battaglia M, Khare M, Barker L . Statistical methodology of the National Immunization Survey, 1994-2002. Vital Health Stat 2. 2005; (138):1-55. View

11.

Kornfield R, Watson S, Higashi A, Conti R, Dusetzina S, Garfield C . Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv. 2013; 64(4):339-46. PMC: 4023684. DOI: 10.1176/appi.ps.201200147. View

12.

Merrill R, Lyon J, Baker R, Gren L . Attention deficit hyperactivity disorder and increased risk of injury. Adv Med Sci. 2009; 54(1):20-6. DOI: 10.2478/v10039-009-0022-7. View

13.

DiScala C, Lescohier I, Barthel M, Li G . Injuries to children with attention deficit hyperactivity disorder. Pediatrics. 1998; 102(6):1415-21. DOI: 10.1542/peds.102.6.1415. View

14.

Cooper W, Habel L, Sox C, Chan K, Arbogast P, Cheetham T . ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011; 365(20):1896-904. PMC: 4943074. DOI: 10.1056/NEJMoa1110212. View

15.

Gould M, Walsh B, Munfakh J, Kleinman M, Duan N, Olfson M . Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009; 166(9):992-1001. DOI: 10.1176/appi.ajp.2009.09040472. View

16.

Wolraich M, Brown L, Brown R, DuPaul G, Earls M, Feldman H . ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011; 128(5):1007-22. PMC: 4500647. DOI: 10.1542/peds.2011-2654. View

17.

Groenman A, Oosterlaan J, Rommelse N, Franke B, Greven C, Hoekstra P . Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry. 2013; 203(2):112-9. DOI: 10.1192/bjp.bp.112.124784. View

18.

Garfield C, Ray Dorsey E, Zhu S, Huskamp H, Conti R, Dusetzina S . Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012; 12(2):110-6. PMC: 3307907. DOI: 10.1016/j.acap.2012.01.003. View

19.

Graf W, Nagel S, Epstein L, Miller G, Nass R, Larriviere D . Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications. Neurology. 2013; 80(13):1251-60. DOI: 10.1212/WNL.0b013e318289703b. View

20.

Molina B, Hinshaw S, Swanson J, Eugene Arnold L, Vitiello B, Jensen P . The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009; 48(5):484-500. PMC: 3063150. DOI: 10.1097/CHI.0b013e31819c23d0. View